Skip to content

LEXILENS - Injection

by Abeye France EUDAMED

Ref ABLT024322C03M, ABLT024322C02M

EMDN Q0299

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number376038410LEXINJDD Basic UDI-DIDate1 Feb 2024RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
LEXILENS - Injection
Model / Reference
ABLT024322C03M, ABLT024322C02M
Primary DI / UDI-DI
03760384100037, 03760384100044
Basic UDI-DI
376038410LEXINJDD
Direct Marketing DI
03760384100037
03760384100044
EMDN Code
Q0299 Ophthalmic devices - other
Device Class
Class I
Market of Registration
France

Manufacturer details

EUDAMED SRN
FR-MF-000033612

Other devices from Abeye

Properties & raw data

Show properties, registry sources and raw records
Other properties (13)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (2)

  • EUDAMED f620a578-bf4b-415c-86af-16e3cc0ee2f7 61 fields · synced 22 Oct 2026
  • EUDAMED ba591a5a-2f59-4038-8797-28a629e81565 61 fields · synced 18 May 2026